Tango Therapeutics, Inc. (NASDAQ: TNGX) last traded at $23.63, down 2.23% on the session. The quote above updates while this page is open; the figures below are drawn from Tango Therapeutics, Inc.’s own filings and are restated only when a new one is published.
Tango Therapeutics, Inc. trades on NASDAQ under the ticker TNGX. Its market capitalisation is $3.98 billion.
Valuation measures for Tango Therapeutics, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $3.98B |
|---|---|
| Enterprise value | $3.69B |
| Price / sales | 74.04 |
| Price / book | 3.89 |
| Beta | 1.32 |
Trailing-twelve-month figures tagged in Tango Therapeutics, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $53.81M |
|---|---|
| Net income (TTM) | -$123.72M |
| EPS (TTM) | -$0.850 |
| Operating margin | -253.38% |
| Return on equity | -12.08% |
| Cash | $345.56M |
Range and volume for TNGX over the past 52 weeks.
| 52-week high | $34.39 |
|---|---|
| 52-week low | $6.69 |
| Volume | 256.0K |
| Average volume | 2.61M |
| Previous close | $24.17 |
Invest a chosen dollar amount in Tango Therapeutics, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell TNGX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.